Arla Foods Ingredients: Pioneering Dairy Innovation

Company Overview

Arla Foods Ingredients (AFI) is a prominent entity in the dairy-derived ingredients sector, headquartered in Viby, Denmark. Known for its pioneering efforts, AFI develops innovative food ingredients that cater to a wide range of sectors including infant formula and sports nutrition.

Facilities and Operations

AFI operates a state-of-the-art production facility located in Videbæk, Denmark, equipped with cutting-edge technology for producing high-quality dairy ingredients. Additionally, the company has established an Innovation Center in Aarhus, Denmark, dedicated to researching and developing groundbreaking food ingredients.

Leadership

Under the leadership of CEO Henrik Andersen, Arla Foods Ingredients has witnessed significant growth and innovation. Andersen's strategic vision has been crucial in propelling the company forward within the dairy industry.

Financial Indicators

Arla Foods Ingredients reported revenues exceeding EUR 800 million, contributing about 10% to the total revenue of the Arla Foods Group. The company experienced remarkable revenue growth of 43.1%, reaching EUR 1.452 billion, which helped mitigate the effects of a market downturn.

Important Company Events

• 2019: Expanded operational capacity with a new lactose manufacturing site in Nr. Vium, Denmark.
• 2021: Launched its first organic micellar casein isolate, catering to the growing demand for organic nutrition products.
• 2022: Introduced Nutrilac® FO-7875, an innovative infant formula ingredient that reduces costs while maintaining high nutritional standards. Additionally, AFI acquired Volac’s Whey Nutrition business, further solidifying its market leadership.

Company Plans

Arla Foods Ingredients is committed to an ambitious growth strategy that includes expanding production capabilities in Asia and the Americas, and investing in research and development for sports, infant, and medical nutrition products. The company emphasizes sustainability by aiming to reduce carbon emissions and enhance energy efficiency.

AFI is adapting to new regulatory changes allowing the declaration of milk fat globule membrane (MFGM) on products across the EU, demonstrating its dedication to quality and innovation. The company has launched Whey360 to emphasize MFGM benefits following EU approval, and expanded its distribution partnership with the Brenntag Group to Southeast Asia.

Furthermore, AFI is entering the performance nutrition market in ANZ/Oceania through a new distribution partnership with Alchemy Agencies. This partnership targets the performance nutrition market in Australia, New Zealand, and the Pacific Islands, featuring five main brands from AFI's premium range.

Arla Foods Ingredients is set to showcase new high-protein food and beverage concepts at the Fi Europe event in Paris. The company plans to present its latest developments in milk and whey protein technologies, including a high-protein transparent yoghurt and a gluten-free high-protein cookie with no added sugar.

Arla Foods Ingredients is introducing its protein bar concept in South America. AFI's bite-sized protein bar concept, featuring the Lacprodan® EasyBar, will debut at the Nutri Ingredients Summit in Brazil. They provide specialized whey and milk protein ingredients for high-protein bars and snacks.

A clinical study has confirmed that Arla Foods Ingredients' Lacprodan IF-3070 supports healthy infant growth. Arla Foods Ingredients developed the partially hydrolysed whey protein Lacprodan IF-3070 and invests heavily in research to ensure the safety and quality of its ingredients.

Modified: 2026/03/31